References
- Mendoza S. A., Reznik V. M., Griswold W. R., Krensky A. M., Yorgin P. D., Tune B. M. Treatment of steroid‐resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 1990; 4: 303–7
- Koutkia P., Mylonakis E., Rounds S., Erickson A. Leucocytoclastic vasculitis: an update for the clinician. Scand J Rheumatol 2001; 30: 315–22
- Singh S., Devidayal, Kumar L., Joshi K., Minz R. W., Datta U. Severe Henoch–Schönlein nephritis: resolution with azathioprine and steroids. Rheumatol Int 2002; 22: 133–7
- Tanaka H., Suzuki K., Nakahata T., Ito E., Waga S. Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 2003; 18: 347–50
- Tarshish P., Bernstein J., Edelmann C. M Jr. Henoch–Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 2004; 19: 51–6
- Niaudet P., Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein–Henoch nephritis. Pediatr Nephrol 1998; 12: 238–43
- Ronkainen J., Autio‐Harmainen H., Nuutinen M. Cyclosporin A for the treatment of severe Henoch–Schönlein glomerulonephritis. Pediatr Nephrol 2003; 18: 1138–42
- Yamamoto‐Shuda Y., Nakayama K., Saito T., Natori Y. Therapeutic effect of glucocorticoid on experimental crescentic glomerulonephritis. J Lab Clin Med 1999; 134: 410–18